Drug Trial Radar · NCT06445023
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria
Last checked: Nov 20, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
963
Actual
Start
Jul 11, 2024
Primary completion
Aug 12, 2026
Study completion Jun 2027
Sponsor
- Lead sponsor
- Celldex TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Jun 6, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to establish the efficacy, safety and tolerability of barzolvolimab in adult participants with Chronic Spontaneous Urticaria (CSU) inadequately controlled by non-sedating second generation H1-antihistamines in comparison to placebo.
Conditions
- Chronic Spontaneous Urticaria
Interventions
barzolvolimabBiological
Subcutaneous Administration
Matching placeboBiological
Matching placebo Subcutaneous Administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change from baseline to Week 12 of UAS7 (Urticaria Activity Score)Time frame: From Day 1 (first dose) to Day 85 (Week 12)
Locations
235 sites in 21 countries. Site status is shown where the registry gives one.
Cahaba Dermatology Skin Health Center
Birmingham, Alabama
First OC Dermatology - Fountain Valley
Fountain Valley, California
310 Clinical Research
Inglewood, California
Dermatology Research Associates
Los Angeles, California
Focus Clinical Research - Los Angeles
Los Angeles, California
Cura Clinical Research
Oxnard, California
Allergy and Asthma Consultants
Redwood City, California
Acclaim Clinical Research
San Diego, California
West Dermatology Research Center
San Diego, California
Therapeutics Clinical Research
San Diego, California
Orso Health, Inc.
Torrance, California
Integrated Research of Inland, Inc.
Upland, California
Western States Clinical Research Inc
Wheat Ridge, Colorado
Encore Medical Research Boynton Beach
Boynton Beach, Florida
Direct Helpers Research Center
Hialeah, Florida
GSI Clinical Research
Margate, Florida
International Dermatology Research Inc - Miami
Miami, Florida
Miami Dade Medical Research Institute, LLC
Miami, Florida
Sarasota Clinical Research
Sarasota, Florida
GCP Global Clinical Professionals, LLC
St. Petersburg, Florida
Paradigm Clinical Research Boise
Boise, Idaho
Endeavor Health
Skokie, Illinois
Dawes Fretzin Clinical Research Group-7910 N Shadeland Ave
Indianapolis, Indiana
DS Research of Kentucky, LLC
Louisville, Kentucky
Allergy and Asthma Specialists PSC
Owensboro, Kentucky
Clinical Trials Management LLC - Southshore Office
Metairie, Louisiana
Johns Hopkins Asthma and Allergy Center
Baltimore, Maryland
DermAssociates, LLC
Rockville, Maryland
Institute For Asthma and Allergy
Wheaton, Maryland
David Fivenson MD Dermatolgy PLLC
Ann Arbor, Michigan
Resp Medicine Research Institute of MI
Ypsilanti, Michigan
Dermatolgy and Skin Cancer Center
Lee's Summit, Missouri
MediSearch, LLC
Saint Joseph, Missouri
Montana Medical Research
Missoula, Montana
Excel Clinical Research - Las Vegas
Las Vegas, Nevada
Allergy Partners of N.J., P.C.
Ocean City, New Jersey
Finger Lakes Medical Research, PLLC
Cortland, New York
Sadick Research Group
New York, New York
Bexley Dermatology Research
Bexley, Ohio
Apex Clinical Research
Canton, Ohio
Showing 40 of 235 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.